Emphysema: all 339 studies
Page 4 of 4. Open to participants first (59), then studies with results posted, then the rest; newest registration first within each.
- Israeli Biologic Lung Volume Reduction (BLVR) Phase 1 Emphysema StudyCompletedNCT00517998Phase 1
- US Biologic Lung Volume Reduction (BLVR) Phase 2 Emphysema StudyCompletedNCT00515164Phase 2
- Clinical Trial to Evaluate the Safety and Effectiveness of the IBV® Valve System for the Treatment of Severe EmphysemaCompletedNCT00475007Not applicable
- US 10 mL Biologic Lung Volume Reduction (BLVR) Phase 2 Emphysema StudyCompletedNCT00435253Phase 2
- TESRA: (Treatment of Emphysema With a Gamma-Selective Retinoid Agonist)CompletedNCT00413205Phase 2
- The Effect of Breathing Helium-Hyperoxia During Pulmonary Rehabilitation in Patients With COPDCompletedNCT00406705Phase 2
- EASE Trial: Exhale Airway Stents for EmphysemaStatus unknownNCT00391612Phase 3
- Real-Time Support for Exercise Persistence in COPDCompletedNCT00373932Phase 1/2
- US 10 mL Biologic Lung Volume Reduction (BLVR) Phase 1 Emphysema StudyCompletedNCT00347659Phase 1
- Macrophages in Smokers' LungWithdrawnNCT00298402
- Use of the Hattler Respiratory Assist Catheter in Severe Respiratory FailureWithdrawnNCT00288964Phase 3
- Evaluating Genes in Sputum to Measure Drug Response in COPDTerminatedNCT00233051Not applicable
- Efficacy Study of the Effect of Budesonide on EmphysemaCompletedNCT00232674Phase 4
- Evaluation of the Lungs of Individuals With Lung DiseaseCompletedNCT00224198
- Exhale (R) Stent for EmphysemaCompletedNCT00207337Phase 2/3
- Netherlands 10 mL Bronchoscopic Lung Volume Reduction (BLVR) Phase 1/2 Emphysema Study - Initial FormulationTerminatedNCT00205920Phase 2
- Israeli 10 mL Bronchoscopic Lung Volume Reduction (BLVR) Phase 1/2 Emphysema Study - Initial FormulationTerminatedNCT00205907Phase 1/2
- Study Comparing Simulect Plus Standard Immunosuppression to Standard Immunosuppression Alone for the Prevention of Acute Rejection and Bronchiolitis Obliterans in Lung TransplantCompletedNCT00188825Phase 3
- Inhaled Steroid Reduces Systemic Inflammation in COPDCompletedNCT00175565Phase 4
- Regulation of Inflammatory Mediators in Chronic Obstructive Pulmonary DiseaseCompletedNCT00147095
- Pilot Study of the Spiration IBV™ SystemCompletedNCT00145548Phase 2
- Endobronchial Valve for Emphysema PalliatioN Trial (VENT) Cost-effectiveness Sub-StudyTerminatedNCT00137956Phase 3
- Endobronchial Valve for Emphysema Palliation Trial (VENT)CompletedNCT00129584Phase 3
- Assessment of Heart and Heart-Lung Transplant Patient Outcomes Following Pulmonary RehabilitationStatus unknownNCT00129350Phase 1
- US 10 mL Bronchoscopic Lung Volume Reduction (BLVR) Phase 1 Emphysema Study - Initial FormulationCompletedNCT00085852Phase 1
- To Evaluate the Long-term Safety of (R,R)-Formoterol in Subjects With COPDCompletedNCT00064415Phase 3
- Determine the Safety and Efficacy of (R,R)-Formoterol in the Treatment of Subjects With COPDCompletedNCT00064402Phase 3
- Yoga for Treating Shortness of Breath in Chronic Obstructive Pulmonary Disease (COPD)CompletedNCT00051792Phase 1/2
- Efficacy of Osteopathic Manipulation in Chronic Obstructive Pulmonary DiseaseCompletedNCT00034112Phase 2
- Lung Volume Reductions Surgery (LVRS) StudyCompletedNCT00018525Not applicable
- Cost-Effectiveness of Lung Volume Reduction SurgeryCompletedNCT00013156Phase 2
- Medication Adherence in COPD--A Self-Regulation StudyCompletedNCT00005717
- Alpha1-antitrypsin Deficiency RegistryCompletedNCT00005292
- Tucson Epidemiology Study of Chronic Obstructive Lung DiseasesCompletedNCT00005279
- Honolulu Heart ProgramCompletedNCT00005123
- Characterization of the Pathobiology of Early Lung Destruction in Alpha 1-Antitrypsin Deficient IndividualsCompletedNCT00001462
- Feasibility of Retinoic Acid Treatment in Emphysema (FORTE)CompletedNCT00000621Phase 2
- National Emphysema Treatment Trial (NETT)CompletedNCT00000606Phase 3
- Emphysema: Physiologic Effects of Nutritional SupportCompletedNCT00000573Phase 2